0001209191-17-044412.txt : 20170707
0001209191-17-044412.hdr.sgml : 20170707
20170707165159
ACCESSION NUMBER: 0001209191-17-044412
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170705
FILED AS OF DATE: 20170707
DATE AS OF CHANGE: 20170707
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iyengar Vijay K
CENTRAL INDEX KEY: 0001670000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 17955691
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-05
0
0000879169
INCYTE CORP
INCY
0001670000
Iyengar Vijay K
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP GPS, BD, & Licensing
Common Stock
2017-07-05
4
A
0
3517
0.00
A
8510
D
Non-Qualified Stock Option (right to buy)
128.34
2017-07-05
4
A
0
11349
0.00
A
2027-07-04
Common Stock
11349
11349
D
Incentive Stock Option (right to buy)
128.34
2017-07-05
4
A
0
779
0.00
A
2027-07-04
Common Stock
779
779
D
Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Dr. Iyengar's continued service with the Issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Includes an aggregate of 4,632 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Beginning July 5, 2017, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
/s/ Vijay K. Iyengar
2017-07-07